Page 1632 - Saunders Comprehensive Review For NCLEX-RN

c. Monitor for visual changes such

as altered color perception and
decreased visual acuity; if changes
occur, withhold the medication and
notify the PHCP.
d. Administer once every 24 hours and
administer with food to decrease
gastrointestinal upset.

e. Monitor uric acid concentration

and assess for painful or swollen joints
or signs of gout.
f. Monitor intake and output and for
adequate renal function.
g. Assess mental status.
h. Monitor for dizziness and initiate safety
precautions.

i. Assess for peripheral neuritis

(numbness, tingling, or burning of the
extremities); if it occurs, notify the
PHCP.

5. Client education

a. That nausea, related to the medication,
can be prevented by taking the daily
dose at bedtime or by taking the
prescribed antinausea medications
b. To notify the PHCP immediately if any
visual problems occur or if a rash;
swelling and pain in the joints; or
numbness, tingling, or burning in the
hands or feet occurs
D. Pyrazinamide
1. Description
a. The exact mechanism of action is
unknown.
b. May be bacteriostatic or bactericidal,
depending on its concentration at the
infection site and on the susceptibility
of the infecting organism
c. Used with at least 1 other antitubercular
medication if ineffectiveness of the
primary medication(s) occurs

1632